Stock 1099 SINOPHARM GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Sinopharm Group Co., Ltd. Stock Shanghai - Hong Kong Stock Connect

Equities

1099

CNE100000FN7

Pharmaceuticals

Financials

Sales 2023 597B 82.4B 645B Sales 2024 * 650B 89.78B 703B Capitalization 57.34B 7.92B 62.03B
Net income 2023 9.05B 1.25B 9.79B Net income 2024 * 9.86B 1.36B 10.66B EV / Sales 2023 0.1 x
Net Debt 2023 * 16.56B 2.29B 17.91B Net Debt 2024 * 3.53B 488M 3.82B EV / Sales 2024 * 0.09 x
P/E ratio 2023
6.41 x
P/E ratio 2024 *
5.83 x
Employees -
Yield 2023 *
4.66%
Yield 2024 *
5.25%
Free-Float 42.99%
More Fundamentals * Assessed data

Chart Sinopharm Group Co., Ltd.

Dynamic Chart

Latest news about Sinopharm Group Co., Ltd.

Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets MT
Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator MT
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue MT
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024 CI
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6% MT
US Inflation, Light News Flow Churns Asian Stock Markets MT
Sinopharm Group Co. Ltd. Announces Change of Registered Address CI
Nomura Adjusts Sinopharm Group’s Price Target to HK$32.39 Form HK$33.31, Keeps at Buy MT
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer MT
China stocks extend gains led by coal, AI; HK shares up RE
Hong Kong Stocks Hover Near Two-Month Highs Amid Mixed Corporate Earnings MT
China stocks jump with AI shares leading on Nvidia forecast; HK shares flat RE
More news

Analyst Recommendations on Sinopharm Group Co., Ltd.

Nomura Adjusts Sinopharm Group’s Price Target to HK$32.39 Form HK$33.31, Keeps at Buy MT
Interest Rates, Earnings, FX Roil Asian Stock Markets MT
Nomura Adjusts Sinopharm Group's Price Target to HK$33.31 From HK$36.28, Keeps at Buy MT
Nomura Adjusts Sinopharm's Price Target to HK$36.28 From HK$36.88, Keeps at Buy MT
UBS Adjusts Sinopharm Group's Price Target to HK$26 From HK$28, Keeps at Buy MT
More recommendations

Press releases Sinopharm Group Co., Ltd.

Sinopharm : 2023 Interim Results Presentation PU
Sinopharm : 2022 Annual Results Presentation PU
Sinopharm : 2022 Interim Report PU
Sinopharm : 2021 Interim Report PU
Sinopharm : FORM OF PROXY FOR DOMESTIC SHAREHOLDERS' CLASS MEETING PU
More press releases

News in other languages on Sinopharm Group Co., Ltd.

MÄRKTE ASIEN/Trotz Zinssenkung erneute Verluste in Hongkong und Schanghai
MORNING BRIEFING - USA/Asien
Borsa: Country Garden in uscita dall'Hang Seng di Hong Kong
MÄRKTE ASIEN/Erneute Abgaben in Hongkong und Schanghai
Crack di Evergrande, si teme una Lehman Brothers cinese
More news

Managers and Directors - Sinopharm Group Co., Ltd.

Managers TitleAgeSince
Yong Liu PSD
 President 55 09-01-08
Shuang Jun Xu PRN
 Corporate Officer/Principal 55 11-02-28
Zhong Xi Cai PRN
 Corporate Officer/Principal 59 10-04-30
Members of the board TitleAgeSince
Qi Yu Chen BRD
 Director/Board Member 52 10-04-30
Xiao Hui Guan BRD
 Director/Board Member 53 19-01-10
Dong Jiu Li BRD
 Director/Board Member 59 13-10-17
More insiders

Company Profile

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
Sector
Pharmaceuticals
Calendar
2024-04-25 - Q1 2024 Earnings Release
Related indices
HONG KONG HANG SENG
More about the company

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
MCKESSON CORPORATION Stock McKesson Corporation
+13.36% 68.18B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+7.33% 25.78B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.34% 7.99B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-24.02% 7.62B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+21.83% 4.45B
EBOS GROUP LIMITED Stock EBOS Group Limited
-2.28% 3.89B
GALENICA AG Stock Galenica AG
-3.51% 3.82B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+25.02% 3.69B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+3.28% 3.24B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 1099 Stock
  4. 1099 Stock